Pine Valley Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-538
Closed -$209K 576
2025
Q2
$209K Buy
538
+41
+8% +$16.5K 0.01% 504
2025
Q1
$216K Buy
+497
New +$200K 0.01% 484
2024
Q4
Sell
-617
Closed -$321K 529
2024
Q3
$321K Buy
617
+17
+3% +$9.08K 0.02% 405
2024
Q2
$325K Buy
600
+53
+10% +$28K 0.02% 369
2024
Q1
$284K Hold
547
0.02% 404
2023
Q4
$258K Sell
547
-26
-5% -$12K 0.02% 409
2023
Q3
$249K Buy
+573
New +$260K 0.02% 395

Other funds holding ELV

Pine Valley Investments's ELV Position: Q3 2025 in Review

Pine Valley Investments sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 538 shares — an estimated $209K sold.

Pine Valley Investments first reported a position in ELV in Q3 2023 and held it in 7 quarters. The position peaked at $325K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Pine Valley Investments reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Pine Valley Investments sold 538 Elevance Health shares in Q3 2025, an estimated $209K.
  • Pine Valley Investments first reported a position in Elevance Health in Q3 2023 and held it in 7 quarters.
  • Pine Valley Investments's Elevance Health position peaked at $325K in Q2 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Pine Valley Investments's 13F filing for Q3 2025, filed 17 Feb 2026.